Magenta Lifecare
Listing performance
Scheduled dates
Tentative timetable — a past date is not confirmation the step completed
Issue details
- IPO date
- 05 Jun 2024 – 07 Jun 2024
- Listing date
- 12 Jun 2024
- Face value
- ₹10 per share
- Issue price
- ₹35 per share
- Lot size
- 4,000 shares
- Issue type
- Fixed Price issue
- Total issue size
- ₹7 Cr
- Market cap at offer price
- ₹24.04 Cr
- Promoter holding
- 84.06% → 59.59% pre-issue → post-issue
- ISIN
- INE0QZ901011
- Registrar
- Cameo Corporate Services Ltd.
- Lead managers
- Fedex Securities Pvt.Ltd.
- Registered office
- N P Patel Estate, A & T Padamla, Gujarat
Reservation and application size
How the issue is split between investor categories, and what each may bid
| Investor category | Shares | % of net | % of total |
|---|---|---|---|
| Market maker | 1,04,000 | — | — |
Application size
Minimum 4,000 shares per lot, in multiples, at ₹35
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (min) | 1 | 4,000 | ₹1,40,000 |
| S-HNI (min) | 2 | 8,000 | ₹2,80,000 |
| S-HNI (max) | 7 | 28,000 | ₹9,80,000 |
| B-HNI (min) | 8 | 32,000 | ₹11,20,000 |
Category limits
| Category | Bid size | Cut-off |
|---|---|---|
| Retail (RII) | Up to ₹2 lakh | Yes |
| Small HNI (sNII) | ₹2 lakh – ₹10 lakh | No |
| Big HNI (bNII) | Above ₹10 lakh | No |
| Employee | Up to ₹5 lakh | Yes |
Bidding at cut-off means accepting the final issue price without naming one. Only retail and employee applicants may do so.
Valuation and performance
Valuation at offer price
| Metric | Pre-issue | Post-issue |
|---|---|---|
| EPS (₹) | 0.50 | 0.47 |
| P/E (×) | 70.00 | 74.47 |
| Price to book (×) | 2.68 | — |
| Market cap | — | ₹24.04 Cr |
Key performance indicators
- Return on net worth
- 3.84%
- ROCE
- 13.41%
- PAT margin
- 4.05%
- NAV per share
- ₹13.07
- Price to book
- 2.68
Single period as reported. Year-on-year movement is in the financials table below, where every period is published.
About Magenta Lifecare
Incorporated on August 04, 2015 as 'Magenta Lifecare Private Limited' in Gujarat and converted into a public limited company named 'Magenta Lifecare Limited' effective July 05, 2023, the company manufactures foam-based products such as mattresses and pillows marketed under the 'Magenta' brand. Its offerings span economy-to-premium mattresses (memory foam, latex-based, bonded, pocketed spring, including green tea and bamboo charcoal herbal variants, pet-bed and travel mattresses) and pillows (memory foam, cervical/contour, ventilated, gel, green tea and bamboo charcoal), alongside processed raw foam and adjustable hydraulic bed frames which it imports under the Magenta brand. It operates a single manufacturing facility at N P Patel Estate, Padamla, Vadodara, with stated installed capacity of 60,000 mattresses and 70,000 pillows, and distributes through 26 distributors and a dealer/retailer network across over 15 states plus online e-commerce platforms, serving retail, hotel and institutional customers. Revenue from operations was ₹906.61 lakhs in FY2023 (₹601.83 lakhs for the period ended December 31, 2023), with profit after tax of ₹24.55 lakhs (₹24.36 lakhs for the period ended December 31, 2023).
Company Analysis
from RHPMagenta Lifecare Limited is a manufacturer of foam-based home comfort products — mattresses, pillows, raw foam and hydraulic adjustable bed frames — sold in India under its own 'Magenta' brand.
Incorporated on August 04, 2015 as 'Magenta Lifecare Private Limited' in Gujarat and converted into a public limited company named 'Magenta Lifecare Limited' effective July 05, 2023, the company manufactures foam-based products such as mattresses and pillows marketed under the 'Magenta' brand. Its offerings span economy-to-premium mattresses (memory foam, latex-based, bonded, pocketed spring, including green tea and bamboo charcoal herbal variants, pet-bed and travel mattresses) and pillows (memory foam, cervical/contour, ventilated, gel, green tea and bamboo charcoal), alongside processed raw foam and adjustable hydraulic bed frames which it imports under the Magenta brand. It operates a single manufacturing facility at N P Patel Estate, Padamla, Vadodara, with stated installed capacity of 60,000 mattresses and 70,000 pillows, and distributes through 26 distributors and a dealer/retailer network across over 15 states plus online e-commerce platforms, serving retail, hotel and institutional customers. Revenue from operations was ₹906.61 lakhs in FY2023 (₹601.83 lakhs for the period ended December 31, 2023), with profit after tax of ₹24.55 lakhs (₹24.36 lakhs for the period ended December 31, 2023).
Objects of the Issue
- Funding the incremental working capital requirements of our Company ₹424.00 lakhs p.21
- General Corporate Purposes ₹174.00 lakhs p.21
Issue Structure
- Total Issue
- Up to ₹700.00 Lakhs (20,00,000 Equity Shares of face value ₹10/- each at ₹35 per Equity Share)
- Fresh Issue
- Up to 20,00,000 Equity Shares aggregating up to ₹700.00 Lakhs
- Offer for Sale
- N.A. — not applicable as the entire issue constitutes a fresh issue of equity shares
- Price Band
- N.A. (100% Fixed Price Issue) — fixed Issue Price of ₹35 per Equity Share, including securities premium of ₹25 per share
- Lot Size
- 4000 Equity Shares and in multiples thereof
- Face Value
- ₹10/- each
Business Model
The company earns revenue by manufacturing and selling branded ('Magenta') foam-based products — mattresses, pillows, raw foam blocks and imported hydraulic adjustable beds — predominantly (~99.9% of revenue) through an offline network of distributors, dealers and multi-brand outlets across more than 15 Indian states, with a marginal contribution from online e-commerce platforms; end-customers span retail, hotels and institutions.
Business Segments
Promoters
| Name | Role | Pre-Issue | Post-Issue |
|---|---|---|---|
| Divyesh Modi | Promoter | 44.33% | 31.42% |
| Khyati Modi | Promoter | 34.19% | 24.24% |
| Vipinchandra Modi | Promoter Group | 5.54% | 3.93% |
Leadership
Auto-extracted from the company's RHP using AI, with each fact linked to its source passage (hover any row to see the quote & page). Provided for research only, not investment advice — verify against the official RHP before relying on it.